![](/img/cover-not-exists.png)
Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer.
Dalal, Kush, Roshan-Moniri, Mani, Sharma, Aishwariya, Li, Huifang, Ban, Fuqiang, Hassona, Mohamed D., Hsing, Michael, Singh, Kriti, LeBlanc, Eric, Dehm, Scott, Tomlinson Guns, Emma S., Cherkasov, ArteVolume:
290
Journal:
Journal of Biological Chemistry
DOI:
10.1074/jbc.A115.553818
Date:
October, 2015
File:
PDF, 35 KB
2015